Current and Novel Treatment Options for Metastatic Colorectal Cancer: Emphasis on Aflibercept

@inproceedings{Dietvorst2013CurrentAN,
  title={Current and Novel Treatment Options for Metastatic Colorectal Cancer: Emphasis on Aflibercept},
  author={M H P Anne-Marie Dietvorst and Ferry A. L. M. Eskens},
  booktitle={Biologics in therapy},
  year={2013}
}
Worldwide, colorectal cancer (CRC) is the third most frequently diagnosed cancer in men and the second in women. Metastatic disease develops in more than half of the patients and carries a poor prognosis. Over the past three decades, significant advances have been made in the treatment of metastatic colorectal cancer (mCRC). The development of new cytotoxic agents and the incorporation of target-specific agents in first-, second-, third-, and nowadays even fourth-line treatment has prolonged… CONTINUE READING